The colonization of immersed surfaces by a myriad of marine organisms is a complex, multi-stage, species-specific process giving rise to economic and environmental costs. This unwanted accumulation of organisms in the marine environment, called biofouling, has been attacked from different fronts, going from the ‘problem-elimination-as-problem-solving’ strategy (essentially through the use of biocides) to more elaborated and environmentally-friendly options based on the principle of ‘non-stick’ or ‘easy foul-release’ surfaces, which do not jeopardize marine life viability. Several marine organisms rely on proteinaceous adhesives to secure a holdfast to surfaces. Proteolytic enzymes have been demonstrated to be effective agents against settlement and settlement consolidation onto surfaces of marine bacteria, algae, and invertebrates, their proposed mode-of-action being the enzymatic degradation of the proteinaceous components of the adhesives. So far, however, the evidence remains inconclusive since most of the published investigations refer to commercial preparations where the enzyme is mixed with other components, like additives, which obviously act as additional experimental variables. This work aims at providing clear, conclusive evidence about the potential of serine proteases to target the adhesives produced by a group of model marine biofoulers. The strategy towards the goal consisted in the preparation and characterization of maleic anhydride copolymer nanocoatings modified by a surface-bound enzyme, Subtilisin A, the active constituent of the commercial preparations reported as effective against biofouling. The enzyme-containing maleic anhydride copolymer films were characterized (enzyme surface concentration, activity, stability, roughness and wettability) and thereafter tested in biological assays with three major biofoulers: spores of the green alga Ulva linza, cells of the pennate diatom Navicula perminuta, and cyprid larvae of the barnacle Balanus amphitrite. The purpose of the biological assays was to elucidate the efficacy of the immobilized catalyst to discourage settlement and/or to facilitate removal of these organisms from the bioactive layers. Results confirmed the initial hypotheses related to the enzymatic degradation of the biological adhesives: the immobilized protease was effective at reducing the adhesion strength of Ulva spores and Navicula diatoms in a manner that correlated with the enzyme activity and surface concentration, and deterred settlement of Balanus amphitrite barnacle cyprids even at the lowest surface activity tested. By facilitating the removal of biofilm-forming diatoms and of spores of the troublesome alga Ulva linza, as well as by interfering with the consolidation of adhesion of the calcareous Balanus amphitrite macrofouler, the enzyme-containing coatings here disclosed are considered to constitute an appealing and promising alternative to control marine biofouling without jeopardizing marine life.

CAR-T-Zell-Therapie ist eine vielversprechende neuartige Behandlungsform für Patienten mit aggressiven B-Zell Non-Hodgkin-Lymphomen (B-NHL). In dieser Arbeit wurde die anti-CXCR5 CAR-T-Zell-Therapie als Alternative zur anti-CD19 CAR-T-Zell-Therapie für die Behandlung von reifen B-NHLs untersucht. CXCR5 ist ein B-Zell-homing Rezeptor, der von reifen B Zellen und follikulären T-Helferzellen (TFH Zellen) exprimiert wird. TFH Zellen wurden als tumor-unterstützend in chronisch lymphatischer Leukämie (CLL) und im follikulären Lymphom (FL) beschrieben. Dieses Expressionsmuster erlaubt es, auf einzigartige Weise zeitgleich die malignen Zellen und die tumorunterstützende Mikroumgebung mithilfe von CAR-T-Zell-Therapie gerichtet gegen einen Chemokinrezeptor anzugreifen. Die wichtigsten Ergebnisse dieser Arbeit waren, dass (1) die anti-CXCR5 CAR T-Zellen zielgerichtet CXCR5 positive reife B-NHL Zelllinien und Patientenproben in vitro eliminierten und eine starke anti-Tumor Reaktivität in einem immundefizienten Xenotransplantationsmausmodell zeigten, (2) die anti-CXCR5 CAR T-Zellen zielgerichtet die tumorunterstützenden TFH Zellen in CLL und FL Patientenproben in vitro erkannten und dass (3) CXCR5 ein sicheres Expressionsprofil zeigte. CXCR5 war stark und häufig auf B-NHL exprimiert und die Expression auf gesundem Gewebe war auf lymphoide Zellen beschränkt. Zusammenfassend lässt sich sagen, dass die anti-CXCR5 CAR-T-Zell-Therapie eine neue Behandlungsmöglichkeit für Patienten mit reifen B-NHL darstellt, indem durch die anti-CXCR5 CAR-T Zellen sowohl der Tumor als auch ein Anteil der tumorunterstützende Mikroumgebung eliminiert werden. Im zweiten Teil der Arbeit wurde das Eμ-Tcl1 murine CLL Lymphommodell genutzt um die Auswirkung der Lymphomentwicklung auf die CXCR5+ T Zellen zu untersuchen. Mittels RNA-Einzelzell-Sequenzierung konnte ein profunder Einfluss des Lymphomwachstums auf das T Zell-Kompartiment der Mäuse, denen Eμ-Tcl1 Zellen gespritzt wurden, gezeigt werden. / CAR T cell therapy is a promising new treatment option for patients suffering from aggressive B non-Hodgkin lymphomas (NHLs). In CAR T cell therapy, patient-derived T cells are genetically modified to express a chimeric receptor commonly directed towards a surface antigen expressed by neoplastic cells. In this thesis, anti-CXCR5 CAR T cell therapy was investigated as an alternative to anti-CD19 CAR T cell therapy for the treatment of mature B-NHLs. CXCR5 is a B cell homing receptor expressed by mature B cells and follicular helper T (TFH) cells. TFH cells were described to support the tumor cells in chronic lymphocytic leukemia (CLL) and follicular lymphoma (FL). This expression pattern allows simultaneous targeting of the malignant cells and the tumor-supporting microenvironment by CAR T cell therapy against a chemokine receptor in an unprecedented manner. Main findings included that (1) anti-CXCR5 CAR T cells targeted specifically CXCR5 expressing mature B-NHL cell lines and patient samples in vitro and showed strong in vivo anti-tumor reactivity in an immunodeficient xenograft mouse model, (2) anti-CXCR5 CAR T cells targeted tumor-supportive TFH cells derived from CLL and FL patient samples in vitro and (3) CXCR5 showed a safe expression profile. CXCR5 was strongly and frequently expressed by B-NHLs and its expression on healthy tissue was restricted to lymphoid cells. In summary, anti-CXCR5 CAR T cell therapy presents a novel treatment option for patients suffering from mature B-NHLs by eliminating the tumor and part of the tumor-supportive microenvironment. The second part of the project, the Eμ-Tcl1 murine lymphoma model, which mimics human CLL, was used to study the impact of lymphomagenesis on CXCR5+ T cells. Using single cell RNA sequencing, a profound influence of lymphoma growth on the T cell compartment in Eμ-Tcl1 tumor-challenged mice could be shown.

The main objective of this work was to manufacture and to characterize detonation nanodiamond (ND) coatings with high biocompatibility and high drug loading capability. This was achieved via the integration of functionalized NDs into standard coating systems. The examination of cell proliferation and cell differentiation supported the biological assessment of the ND-enhanced coatings. As a first step, an osteogenic peptide was covalently grafted onto oxidized NDs. Accordingly, carboxylic acid derivativ is were generated on the as-received ND surface via an optimized heat treatment. The osteogenic peptide was tethered to the oxidized ND surface using a carbodiimide crosslinking method. The multifaceted ND preparation and disaggregation facilitated the powder handling during the conjugation process. Moreover, antibiotics were physisorbed onto as-received NDs to add antimicrobial properties. The correlated surface loading of NDs was determined using various absorption spectroscopy methods such as fluorescence and ultraviolet-visible spectroscopy. Peptide-conjugated NDs and NDs with untreated surface chemistry have been immobilized on different biomaterials using liquid phase deposition techniques. Herein, polyelectrolyte multilayers (PEMs) were utilized, among others, due to their self-organization and universal applicability for numerous substrates. In order to assess the cell-material interactions, human fetal osteoblasts (hFOBs) were cultured. The hFOBs exhibited a high cell proliferation, high cell density, and sound cellular adhesion, which proves the high biocompatibility of PEMs containing NDs. The present study represents a novel and reliable strategy towards a public approved composite coating. The potential of NDs as a biocompatible delivery platform and as a coating material for biomaterials has been demonstrated. This technology will be useful for the development and optimization of next-generation drug delivery vehicles, e.g. drug-eluting coatings, as well as for biomaterials in general.:Abstract i Kurzfassung iii List of Figures v List of Tables vi Abbreviations vii 1 Introduction and Objectives 1 1.1 Scope of the Thesis 3 2 Fundamentals 9 2.1 Overview of Biomaterials 9 2.2 Surface Modification Techniques of Biomaterials 11 2.3 Cellular Response to Tailored Biomaterials 13 2.4 Essential Features of Detonation Nanodiamonds 15 2.4.1 Biomedical Applications 16 2.4.2 Chemical Functionalization Pathways 19 2.4.3 Colloidal Stability 21 3 Materials and Methods 25 3.1 Wet Chemical and High-temperature Oxidation of Detonation Nanodiamonds 26 3.2 Disaggregation of Detonation Nanodiamond Agglomerates 26 3.3 Grafting of Biomolecules onto Detonation Nanodiamonds 27 3.4 Macroscopic Surface Modification of Biomaterials 28 3.5 Characterization Techniques 30 3.5.1 Morphology 30 3.5.2 Colloidal Stability and ND Crystal Structure 30 3.5.3 ND Surface Chemistry and Surface Loading 31 3.5.4 Alkaline Phosphatase Activity of Human Mesenchymal Stem Cells 31 3.5.5 Cell Viability and Immunofluorescence Staining of Human Fetal Osteoblasts 32 4 Surface Modification of Detonation Nanodiamonds 35 4.1 Comparison of Wet Chemical and High-temperature Oxidation 35 4.1.1 Absorption Spectroscopy 35 4.1.2 Crystal Structure of Dry-oxidized NDs 37 4.2 Chemisorption of Bone Morphogenetic Protein-2 Derived Peptide 38 4.3 Physisorption of Amoxicillin 42 4.4 Conclusions 44 5 Coatings Exhibiting Detonation Nanodiamonds 47 5.1 Colloidal Stability of Aqueous ND Suspensions 47 5.1.1 ND Agglomerate Size and Zeta Potential Measurement 47 5.1.2 Influence of pH and Ion Concentration 50 5.2 Electrophoretic Deposition and Covalent Attachmen 51 5.3 Polyelectrolyte Multilayers 55 5.4 Conclusions 56 6 Biological Assessment of Detonation Nanodiamond Coatings 59 6.1 Alkaline Phosphatase Activity of Mesenchymal Stem Cells 59 6.2 Cellular Response of Osteoblasts 61 6.2.1 Cell Morphology 61 6.2.2 Cell Adhesion . 64 6.2.3 Cell Viability 66 6.3 Conclusions 68 7 Summary and Outlook 71 Acknowledgements 77 References 79 Appendix 109 List of Publications 113 / Das Hauptziel der Arbeit bestand in der Herstellung sowie der Charakterisierung von Beschichtungen aus Detonationsnanodiamanten (ND), welche eine hohe Biokompatibilität und eine hoheWirkstoffbeladbarkeit aufweisen sollten. Dieses Ziel wurde durch die Integration funktionalisierter ND in herkömmliche Beschichtungssysteme erreicht. Die biologische Beurteilung von den ND-verstärkten Beschichtungen wurde durch Untersuchungen der Zellproliferation und der Zelldifferenzierung untermauert. Im ersten Schritt wurde ein Peptid mit knochenbildenden Eigenschaften kovalent an oxidierte ND angebunden. Mittels einer optimierten Wärmebehandlung wurden Carbonsäurederivate auf der ND-Oberfläche erzeugt. Anschließend wurde das Peptid unter Verwendung eines Carbodiimid-Vernetzungsmittels an die oxidierte ND-Oberfläche angebunden. Während des Konjugationsprozesses erleichterte die facettenreiche ND-aufbereitung und -disaggregation die Pulverhandhabung. Außerdem wurden Antibiotika auf den ND adsorbiert, um antimikrobielle Eigenschaften zu erzeugen. Die entsprechende Oberflächenbeladung der ND wurde unter Verwendung verschiedener absorptionsspektroskopischer Ansätze wie Fluoreszenz- und UV/Vis-Spektroskopie bestimmt. Biofunktionale und unbehandelte ND wurden über Flüssigphasenabscheidung auf verschiedene Biomaterialien aufgebracht. Hierbei wurden unter anderem Polyelektrolyt-Mehrschichtsysteme aufgrund ihrer Selbstorganisation und universellen Anwendbarkeit auf zahlreiche Substrate eingesetzt. Um die Zellantwort auf die mehrschichtigen ND zu bewerten, wurden humane Osteoblasten (hFOB) kultiviert. Die hFOB zeigten eine hohe Zellproliferation, eine hohe Zelldichte und eine hohe Zelladhäsion, was die hohe Biokompatibilität von mehrschichtigen ND belegt. Die vorliegende Arbeit stellt eine neuartige und zuverlässige Strategie für eine allgemein anerkannte Verbundbeschichtung dar. Das Potenzial von ND als biokompatible Medikamententräger und als Beschichtungsmaterial für Biomaterialien konnte aufgezeigt werden. Die dargestellte Technologie kann für die Entwicklung und Optimierung von Medikamententrägern der nächsten Generation, z. B. in arzneimittelfreisetzenden Beschichtungen, sowie für Biomaterialien im Allgemeinen verwendet werden.:Abstract i Kurzfassung iii List of Figures v List of Tables vi Abbreviations vii 1 Introduction and Objectives 1 1.1 Scope of the Thesis 3 2 Fundamentals 9 2.1 Overview of Biomaterials 9 2.2 Surface Modification Techniques of Biomaterials 11 2.3 Cellular Response to Tailored Biomaterials 13 2.4 Essential Features of Detonation Nanodiamonds 15 2.4.1 Biomedical Applications 16 2.4.2 Chemical Functionalization Pathways 19 2.4.3 Colloidal Stability 21 3 Materials and Methods 25 3.1 Wet Chemical and High-temperature Oxidation of Detonation Nanodiamonds 26 3.2 Disaggregation of Detonation Nanodiamond Agglomerates 26 3.3 Grafting of Biomolecules onto Detonation Nanodiamonds 27 3.4 Macroscopic Surface Modification of Biomaterials 28 3.5 Characterization Techniques 30 3.5.1 Morphology 30 3.5.2 Colloidal Stability and ND Crystal Structure 30 3.5.3 ND Surface Chemistry and Surface Loading 31 3.5.4 Alkaline Phosphatase Activity of Human Mesenchymal Stem Cells 31 3.5.5 Cell Viability and Immunofluorescence Staining of Human Fetal Osteoblasts 32 4 Surface Modification of Detonation Nanodiamonds 35 4.1 Comparison of Wet Chemical and High-temperature Oxidation 35 4.1.1 Absorption Spectroscopy 35 4.1.2 Crystal Structure of Dry-oxidized NDs 37 4.2 Chemisorption of Bone Morphogenetic Protein-2 Derived Peptide 38 4.3 Physisorption of Amoxicillin 42 4.4 Conclusions 44 5 Coatings Exhibiting Detonation Nanodiamonds 47 5.1 Colloidal Stability of Aqueous ND Suspensions 47 5.1.1 ND Agglomerate Size and Zeta Potential Measurement 47 5.1.2 Influence of pH and Ion Concentration 50 5.2 Electrophoretic Deposition and Covalent Attachmen 51 5.3 Polyelectrolyte Multilayers 55 5.4 Conclusions 56 6 Biological Assessment of Detonation Nanodiamond Coatings 59 6.1 Alkaline Phosphatase Activity of Mesenchymal Stem Cells 59 6.2 Cellular Response of Osteoblasts 61 6.2.1 Cell Morphology 61 6.2.2 Cell Adhesion . 64 6.2.3 Cell Viability 66 6.3 Conclusions 68 7 Summary and Outlook 71 Acknowledgements 77 References 79 Appendix 109 List of Publications 113

Pancreatic β-cells have a central function in the regulation of glucose homeostasis by releasing the blood sugar-lowering hormone insulin. Disruption of this process results in diabetes, which has a tremendous impact on the quality of life and requires lifelong treatment. Elucidating the mechanisms of pancreatic progenitor cell differentiation into fully functional β-cells will contribute to identifying the underlying reasons for β-cell dysfunction and to finding a cure for diabetes. Aldh1b1 was identified by our research group as a regulator of pancreas development and β-cell functionality. Aldh1b1 is a mitochondrial enzyme, expressed in all embryonic pancreas progenitors. Its expression is switched off during the process of differentiation and is undetectable in differentiated cells. Functional inactivation of Aldh1b1 in the mouse leads to premature differentiation of progenitor cells in the embryo and dysfunctional β-cells in the adult. However, the enzymatic function of Aldh1b1 in pancreas progenitors and how it ultimately affects β-cell functionality remained to be elucidated. In this study, I analyzed the role of Aldh1b1 in the metabolism of embryonic pancreas progenitor cells and its impact on chromatin structure and gene expression in both, progenitors and postnatal β-cells. Flow cytometry analysis of freshly isolated Aldh1b1 null embryonic pancreas progenitors showed a significant increase in ROS levels as well as a significant decrease in mitochondrial mass, whereas the mitochondrial membrane potential was not affected. To elucidate the impact of Aldh1b1 on cellular metabolism, I conducted metabolic flux experiments and untargeted metabolomics studies using FACS-isolated embryonic pancreas progenitors expanded in a 3D spheroid culture. Analyses following metabolic labeling with either 13C6-Glucose or 13C2-Glutamine showed that the absence of Aldh1b1 lead to an increase of the reductive glutamine metabolism towards citrate, a reaction that channels carbon units into the acetyl-CoA biosynthesis. However, the ACLy-dependent flux towards acetyl-coA synthesis was reduced and this was consistent with reduced expression of ACLy as well as the citrate transporter SLC25a1. A decrease in cellular acetyl-CoA would reduce histone acetylation. Untargeted metabolomics showed an increase in the concentration of S-adenosyl-methionine, suggesting increased DNA and histone methylation. Consistent with these findings, ATAC-Seq analyses on freshly isolated pancreatic progenitors showed reduced chromatin accessibility at genes implicated in chromatin organization, protein acetylation and histone modification. Transcription motif analysis showed that the affected genomic sites were mainly associated with the binding of Klf/Sp and Nrf1 transcription factors. Transcriptome analyses displayed that the expression of genes implicated in progenitor differentiation, ECM organization and transcriptional regulation was affected. Furthermore, transcriptome analyses of early postnatal β-cells uncovered early signs of oxidative stress and increased proliferation, thus providing the basis to explain the β-cell phenotype in Aldh1b1 null mice. I then used organotypic cultures of embryonic pancreata to investigate the connection between high ROS levels and aberrant differentiation in the Aldh1b1 null pancreata. Reducing ROS levels using NAC enabled the reversal of the aberrant transcription factor expression and increased viability of Aldh1b1 null explants, thus identifying high ROS levels as a driving force in this process. To investigate how persisting Aldh1b1 expression would affect progenitor differentiation, I generated ROSA26LSLAldh1b1, an inducible constitutive Aldh1b1 expression line. Progenitors with continuous Aldh1b1 expression avoided the endocrine cell fate, underscoring the importance of timely Aldh1b1 downregulation in the course of β-cell differentiation. Altogether, my work provides strong evidence for the role of Aldh1b1 as a metabolic regulator in the process of progenitor cell differentiation and identifies a link between metabolism and gene regulation through chromatin accessibility during development. Aldh1b1 inactivity causes defects in embryonic progenitor cells as well as postnatal β-cells and could therefore contribute, as genetic risk factor, to the development of hyperglycemia and diabetes later in life. Comprehending the mechanisms underlying the process of pancreas progenitor differentiation as well as the origins of β cell dysfunction should assist in the design of novel therapeutic interventions for diabetes.

In T cells, processes such as migration and immunological synapse formation are accompanied by the dynamic reorganization of the actin cytoskeleton, which has been suggested to be mediated by regulators of RhoGTPases and by F-actin bundlers. SWAP-70 controls F-actin dynamics in various immune cells, but its role in T cell development and function has remained incompletely understood. CD4+ regulatory T (Treg) cells expressing the transcription factor Foxp3 employ diverse mechanisms to suppress innate and adaptive immunity, which is critical for maintaining immune homeostasis and self-tolerance. Here, we propose Swap-70 as a novel member of the Foxp3-dependent canonical Treg cell signature. We show that Swap-70-/- mice have increased numbers of Foxp3+ Treg cells with an effector/memory-like phenotype that exhibit impaired suppressor function in vitro, but maintain overall immune homeostasis in vivo. Upon formation of an immunological synapse with antigen presenting cells in vitro, cytosolic SWAP-70 protein is selectively recruited to the interface in Treg cells. In this context, Swap-70-/- Treg cells fail to downregulate CD80/CD86 on osteoclast precursor cells by trans-endocytosis and to efficiently suppress osteoclastogenesis and osteoclast function. These data provide first evidence for a crucial role of SWAP-70 in Treg cell biology and further highlight the important non-immune function of Foxp3+ Treg cells in bone homeostasis mediated through direct SWAP-70-dependent mechanisms.

Der adoptive Transfer von T-Zell-Rezeptor (TZR) modifizierten T-Zellen gegen krebsspezifische Antigene ist ein vielversprechender Ansatz in der Immuntherapie. Geeignete Zielmoleküle für diese Therapie sollten wichtig für das Überleben von Krebszellen sein und zudem in ausreichenden Mengen auf der Zelloberfläche exprimiert werden, um von T-Zellen erkannt zu werden. Die Identifizierung dieser Zielmoleküle ist jedoch eine Herausforderung und erfordert eine intensive Charakterisierung, um eine ausreichende Prozessierung und Präsentation auf den Tumorzellen zu validieren. Ziel dieser Arbeit war, HLA-A2-spezifische Neoepitope als Zielmoleküle für adoptive T-Zell-Therapie zu validieren. Dafür wurden erfolgreich Immunantworten in einem humanen transgenen Mausmodell nach Peptidimmunisierung induziert und TZRs mit hoher Affinität isoliert. Trotz einer hohen funktionellen Avidität von H3.3K27M-spezifischen T-Zellen wurde keine Erkennung von Tumorzellen erreicht. Zweitens wurden TZR-transduzierte T-Zellen gegen die häufige Melanommutation Rac1P29S isoliert, welche zytotoxisch gegen Melanomzelllinien waren. Letztlich wurde beobachtetet, dass TZRs mit hoher Affinität gegen gespleißte Kras und Rac2 Epitope, welche durch Proteasom-katalysiertes Peptidspleißen erzeugt wurden, keine Immunantwort gegen endogen exprimierte Mutationen hervorrufen konnten. Daraus lässt sich schließen, dass gespleißte Epitope wahrscheinlich seltener vorkommen als zuvor angenommen und daher möglicherweise irrelevant für die adoptive T-Zelltherapie sind. Diese Daten deuten darauf hin, dass die Auswahl von Zielmolekülen für die adoptive T-Zell-Therapie mit Hilfe reverser Immunologie auf der Grundlage von Bindungsalgorithmen und der Häufigkeit von Mutationen allein nicht ausreicht. Daher sind vor der Isolierung und Charakterisierung von TZRs zusätzliche Strategien wie z.B. die Analyse des MHC-Immunopeptidoms erforderlich, um die Auswahl geeigneter Zielmoleküle für die T-Zelltherapie zu verbessern. / Adoptive transfer of T cell receptor (TCR)-engineered T cells against tumour-specific neoantigens is a promising approach in cancer immunotherapy. Ideally, targeted antigens are crucial for cancer cell survival and are generated in sufficient amounts to be recognised by T cells. However, the identification of ideal targets remains challenging and requires intensive characterisation to validate sufficient antigen processing and presentation by the tumour cells. This thesis focused on the validation of HLA-A2 binding neoepitopes carrying the recurrent cancer mutations H3.3K27M, Rac1P29S, Rac2P29L or KrasG12V as targets for adoptive T cell therapy. After peptide immunisation, immune responses in a human transgenic mouse model were elicited and high-affinity TCRs successfully isolated. Although H3.3K27M-specific T cells showed high functional avidity, no recognition of cells endogenously expressing mutant H3.3 was achieved. Furthermore, a mechanism to target the common melanoma mutation Rac1P29S with a TCR raised against a heterologous mutation with higher peptide-MHC affinity was described. TCR-transduced T cells induced cytotoxicity against Rac1P29S expressing melanoma cell lines. Lastly, high-affinity TCRs specific for mutant Kras and Rac2 spliced epitopes generated by proteasome-catalysed peptide splicing were successfully isolated, however, TCR-transduced T cells did not induce an immune response against endogenously expressed mutant transgenes. The results indicate that spliced epitopes are probably less abundant than previously estimated and therefore may play a minor role in the generation of targets for adoptive T cell therapy. These data suggest that target selection using a reverse immunology approach based on binding algorithms and frequency of mutations alone is not sufficient. Thus, additional strategies to improve the selection of suitable targets such as the analysis of the MHC immunopeptidome are required prior to TCR isolation and characterisation.

CD8+ T Zellen unterstützen die Beseitigung von Pathogenen und sind somit entscheidend bei der Bekämpfung von Infektionen. Neben der Antigendosis und dem inflammatorischen Zytokinemilieu hat auch die Stimulation durch den TZR einen entscheidenden Einfluss auf die CD8+ T Zellantwort. Das transkriptionelle Programm, die finale Größe und Dauer der klonalen Expansion und der Start der Kontraktionsphase werden durch die TZR-Signalstärke bestimmt. Schwache TZR-Stimulation führt zu einer verminderten Expansion und vermittelt eine frühzeitige Kontraktionsphase, die eine Entwicklung von Gedächtniszellen auf den Kosten der Effektorzellen favorisiert. IRF4 wird nach TZR-Ligand-Interaktion in CD8+ T-Zellen hoch reguliert. Seine Expressionskinetik ist stark von der TZR-Signalstärke der Aktivierung abhängig, übersetzt diese und sorgt für die Umsetzung in ein entsprechendes transkriptionelles und differentielles Programm. In dieser Arbeit konnte erstmals gezeigt werden, dass die IRF4-Defizienz in CD8+ T-Zellen zu einem verfrühten Abbruch der Expansion und zu einem vorzeitigen Beginn der Kontraktion führt, die durch den FAS-vermittelten Tod-induzierenden Signalweg initiiert wird. Außerdem präsentieren IRF4-defiziente CD8+ T-Zellen vermehrt Phosphatidylserine an ihrer Oberfläche und Komplementdeposition, beides begünstigt die Erkennung und Aufnahme durch Phagozyten. Diese Ergebnisse weisen zudem stark darauf hin, dass durch die fehlende Expression von IRF4 in CD8+ T Zellen, ein schwaches TZR-Signal übermittelt wird, unabhängig von der tatsächlichen Stärke und Dauer des aktivierenden Signals, dass zu einer Verkürzung der Expansionsphase führt und eine verfrühte Kontraktionsphase der Effektorzellen auslöst. Diese Arbeit erweitert schon bekanntes Wissen um IRF4 als Schlüsselregulator für die Differenzierung und Funktionalität der ag-spezifischen CD8+ T-Zellen, da es den Beginn der Kontraktionsphase diktiert mittels Aktivierung von verschiedenen Apoptose- und Phagocytose Signalwegen. / CD8+ T cells promote pathogen clearance and play a crucial role in controlling infections. Besides antigen dose and inflammatory cytokine milieu, the TCR stimulation contributes to the programming of the CD8+ T cell response. A distinct developmental program, the final magnitude and duration of clonal expansion, as well as the timing of the onset of T cell contraction, are determined by the TCR signaling strength. Weak TCR stimulation results in a diminished magnitude of expansion and accelerates the onset of contraction, as it favors the development of memory cells at the expense of effector cells. IRF4 is a transcription factor, that is upregulated in CD8+ T cells following TCR stimulation. Furthermore, its expression kinetic is highly dependent on the TCR signaling strength, which initiated activation. Therefore, it translates the strength of the activating signal and transmits it into a proper transcriptional and developmental program. This study provides unique evidence that the absence of IRF4 expression in CD8+ T cells leads to a hasted termination of clonal expansion and a premature contraction, initiated by the FAS-mediated cell death pathway. Moreover, IRF4-deficient CD8+ T cells exposed phosphatidylserine on their cell surface and showed complement deposition, both facilitating their recognition and uptake by phagocytes. The findings of this study additionally strongly indicate that IRF4 deficiency mimics weak TCR engagement and in turn transmits every TCR signal, independent of its actually affinity and duration, into a developmental program, that give rise to an early memory formation and results in a premature onset of effector CD8+ T cell contraction. This data extend previous knowledge of IRF4 being essential for the differentiation and functionality of ag-specific effector CD8+ T cells, as it furthermore dictates the onset of CD8+ T cell contraction via the activation of several death and phagocytosis inducing pathways.

During mitosis, adherent animal cells undergo a drastic shape change, from essentially flat to round, in a process known as mitotic cell rounding (MCR). The aim of this thesis was to critically examine the physical and biological basis of MCR. The experimental part of this thesis employed a combined optical microscope-atomic force microscope (AFM) setup in conjunction with flat tipless cantilevers to analyze cell mechanics, shape and volume. To this end, two AFM assays were developed: the constant force assay (CFA), which applies constant force to cells and measures the resultant height, and the constant height assay (CHA), which confines cell height and measures the resultant force. These assays were deployed to analyze the shape and mechanical properties of single cells trans-mitosis. The CFA results showed that cells progressing through mitosis could increase their height against forces as high as 50 nN, and that higher forces can delay mitosis in HeLa cells. The CHA results showed that mitotic cells confined to ~50% of their normal height can generate forces around 50-100 nN without disturbing mitotic progression. Such forces represent intracellular pressures of at least 200 Pascals and cell surface tensions of around 10 nN/µm. Using the CHA to compare mitotic cell rounding with induced cell rounding, it was observed that the intracellular pressure of mitotic cells is at least 3-fold higher than rounded interphase cells. To investigate the molecular basis of the mechanical changes inherent in mitotic cell rounding, inhibitors and toxins were used to pharmacologically dissect the role of candidate cellular processes. These results implicated the actomyosin cortex and osmolyte transporters, the most prominent of which is the Na+/H+ exchanger, in the maintenance of mechanical properties and intracellular hydrostatic pressure. Observations on blebbing cells under the cantilever supported the idea that the actomyosin cortex is required to sustain hydrostatic pressure and direct this pressure into cell shape changes. To gain further insight into the relationship between actomyosin activity and intracellular pressure, dynamic perturbation experiments were conducted. To this end, the CHA was used to evaluate the pressure and volume of mitotic cells before, during and after dynamic perturbations that included tonic shocks, influx of specific inhibitors, and exposure to pore-forming toxins. When osmotic pressure gradients were depleted, pressure and volume decreased. When the actomyosin cytoskeleton was abolished, cell volume increased while rounding pressure decreased. Conversely, stimulation of actomyosin cortex contraction triggered an increase in rounding pressure and a decrease in volume. Taken together, the dynamic perturbation results demonstrated that the actomyosin cortex contracts against an opposing intracellular pressure and that this relationship sets the surface tension, pressure and volume of the cell. The discussion section of this thesis provides a comprehensive overview of the physical basis of MCR by amalgamating the experimental results of this thesis with the literature. Additionally, the biochemal signaling pathways and proteins that drive MCR are collated and discussed. An exhaustive and unprecedented synthesis of the literature on cell rounding (approx. 750 papers as pubmed search hits on “cell rounding”, April 2012) reveals that the spread-to-round transition can be thought of in terms of a surface tension versus adhesion paradigm, and that cell rounding can be physically classified into four main modes, of which one is an MCR-like category characterized by increased actomyosin cortex tension and diminution of focal adhesions. The biochemical pathways and signaling patterns that correspond with these four rounding modes are catalogued and expounded upon in the context of the relevant physiology. This analysis reveals cell rounding as a pertinent topic that can be leveraged to yield insight into core principles of cell biophysics and tissue organization. It furthermore highlights MCR as a model problem to understand the adhesion versus cell surface tension paradigm in cells and its fundamentality to cell shape, mechanics and physiology.

During mitosis, adherent animal cells undergo a drastic shape change, from essentially flat to round, in a process known as mitotic cell rounding (MCR). The aim of this thesis was to critically examine the physical and biological basis of MCR. The experimental part of this thesis employed a combined optical microscope-atomic force microscope (AFM) setup in conjunction with flat tipless cantilevers to analyze cell mechanics, shape and volume. To this end, two AFM assays were developed: the constant force assay (CFA), which applies constant force to cells and measures the resultant height, and the constant height assay (CHA), which confines cell height and measures the resultant force. These assays were deployed to analyze the shape and mechanical properties of single cells trans-mitosis. The CFA results showed that cells progressing through mitosis could increase their height against forces as high as 50 nN, and that higher forces can delay mitosis in HeLa cells. The CHA results showed that mitotic cells confined to ~50% of their normal height can generate forces around 50-100 nN without disturbing mitotic progression. Such forces represent intracellular pressures of at least 200 Pascals and cell surface tensions of around 10 nN/µm. Using the CHA to compare mitotic cell rounding with induced cell rounding, it was observed that the intracellular pressure of mitotic cells is at least 3-fold higher than rounded interphase cells. To investigate the molecular basis of the mechanical changes inherent in mitotic cell rounding, inhibitors and toxins were used to pharmacologically dissect the role of candidate cellular processes. These results implicated the actomyosin cortex and osmolyte transporters, the most prominent of which is the Na+/H+ exchanger, in the maintenance of mechanical properties and intracellular hydrostatic pressure. Observations on blebbing cells under the cantilever supported the idea that the actomyosin cortex is required to sustain hydrostatic pressure and direct this pressure into cell shape changes. To gain further insight into the relationship between actomyosin activity and intracellular pressure, dynamic perturbation experiments were conducted. To this end, the CHA was used to evaluate the pressure and volume of mitotic cells before, during and after dynamic perturbations that included tonic shocks, influx of specific inhibitors, and exposure to pore-forming toxins. When osmotic pressure gradients were depleted, pressure and volume decreased. When the actomyosin cytoskeleton was abolished, cell volume increased while rounding pressure decreased. Conversely, stimulation of actomyosin cortex contraction triggered an increase in rounding pressure and a decrease in volume. Taken together, the dynamic perturbation results demonstrated that the actomyosin cortex contracts against an opposing intracellular pressure and that this relationship sets the surface tension, pressure and volume of the cell. The discussion section of this thesis provides a comprehensive overview of the physical basis of MCR by amalgamating the experimental results of this thesis with the literature. Additionally, the biochemal signaling pathways and proteins that drive MCR are collated and discussed. An exhaustive and unprecedented synthesis of the literature on cell rounding (approx. 750 papers as pubmed search hits on “cell rounding”, April 2012) reveals that the spread-to-round transition can be thought of in terms of a surface tension versus adhesion paradigm, and that cell rounding can be physically classified into four main modes, of which one is an MCR-like category characterized by increased actomyosin cortex tension and diminution of focal adhesions. The biochemical pathways and signaling patterns that correspond with these four rounding modes are catalogued and expounded upon in the context of the relevant physiology. This analysis reveals cell rounding as a pertinent topic that can be leveraged to yield insight into core principles of cell biophysics and tissue organization. It furthermore highlights MCR as a model problem to understand the adhesion versus cell surface tension paradigm in cells and its fundamentality to cell shape, mechanics and physiology.

Background: Sphingosine 1-phosphat receptor modulators (S1PRMs) have been linked to attenuated immune response to SARS-CoV-2 vaccines. Objective: To characterize differences in the immune response to SARS-CoV-2 vaccines in patients on selective versus unselective S1PRMs. Methods: Monocentric, longitudinal study on people with multiple sclerosis (pwMS) on fingolimod (FTY), siponimod (SIP), ozanimod (OZA), or without disease-modifying therapy (DMT) following primary and booster SARS-CoV-2 vaccination. Anti-SARS-CoV-2 antibodies and T-cell response was measured with electro-chemiluminescent immunoassay and interferon-γ release assay. Results: Primary vaccination induced a significant antibody response in pwMS without DMT while S1PRM patients exhibited reduced antibody titers. The lowest antibodies were found in patients on FTY, whereas patients on OZA and SIP presented significantly higher levels. Booster vaccinations induced increased antibody levels in untreated patients and comparable titers in patients on OZA and SIP, but no increase in FTY-treated patients. While untreated pwMS developed a T-cell response, patients on S1PRMs presented a diminished/absent response. Patients undergoing SARS-CoV-2 vaccination before onset of S1PRMs presented a preserved, although attenuated humoral response, while T-cellular response was blunted. Conclusion: Our data confirm differential effects of selective versus unselective S1PRMs on T- and B-cell response to SARS-CoV-2 vaccination and suggest association with S1PRM selectivity rather than lymphocyte redistribution.